| UniProt ID | INO1_HUMAN | |
|---|---|---|
| UniProt AC | Q9NPH2 | |
| Protein Name | Inositol-3-phosphate synthase 1 | |
| Gene Name | ISYNA1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 558 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Key enzyme in myo-inositol biosynthesis pathway that catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol 1-phosphate in a NAD-dependent manner. Rate-limiting enzyme in the synthesis of all inositol-containing compounds.. | |
| Protein Sequence | MEAAAQFFVESPDVVYGPEAIEAQYEYRTTRVSREGGVLKVHPTSTRFTFRTARQVPRLGVMLVGWGGNNGSTLTAAVLANRLRLSWPTRSGRKEANYYGSLTQAGTVSLGLDAEGQEVFVPFSAVLPMVAPNDLVFDGWDISSLNLAEAMRRAKVLDWGLQEQLWPHMEALRPRPSVYIPEFIAANQSARADNLIPGSRAQQLEQIRRDIRDFRSSAGLDKVIVLWTANTERFCEVIPGLNDTAENLLRTIELGLEVSPSTLFAVASILEGCAFLNGSPQNTLVPGALELAWQHRVFVGGDDFKSGQTKVKSVLVDFLIGSGLKTMSIVSYNHLGNNDGENLSAPLQFRSKEVSKSNVVDDMVQSNPVLYTPGEEPDHCVVIKYVPYVGDSKRALDEYTSELMLGGTNTLVLHNTCEDSLLAAPIMLDLALLTELCQRVSFCTDMDPEPQTFHPVLSLLSFLFKAPLVPPGSPVVNALFRQRSCIENILRACVGLPPQNHMLLEHKMERPGPSLKRVGPVAATYPMLNKKGPVPAATNGCTGDANGHLQEEPPMPTT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 27 (in isoform 2) | Ubiquitination | - | 14.34 | 21890473 | |
| 40 | Ubiquitination | SREGGVLKVHPTSTR EEECCEEEECCCCCC | 35.77 | 21906983 | |
| 40 (in isoform 1) | Ubiquitination | - | 35.77 | 21890473 | |
| 72 | Phosphorylation | GWGGNNGSTLTAAVL EECCCCHHHHHHHHH | 23.51 | 22210691 | |
| 73 | Phosphorylation | WGGNNGSTLTAAVLA ECCCCHHHHHHHHHH | 29.53 | 22210691 | |
| 75 | Phosphorylation | GNNGSTLTAAVLANR CCCHHHHHHHHHHHH | 16.80 | 22210691 | |
| 86 | Phosphorylation | LANRLRLSWPTRSGR HHHHCCCCCCCCCCC | 25.28 | 23403867 | |
| 89 | Phosphorylation | RLRLSWPTRSGRKEA HCCCCCCCCCCCCEE | 31.07 | 25002506 | |
| 91 | Phosphorylation | RLSWPTRSGRKEANY CCCCCCCCCCCEEEE | 45.48 | 25002506 | |
| 94 (in isoform 2) | Ubiquitination | - | 65.78 | 21890473 | |
| 101 | Ubiquitination | KEANYYGSLTQAGTV CEEEEEECCCCCEEE | 16.48 | 21890473 | |
| 155 | Ubiquitination | AEAMRRAKVLDWGLQ HHHHHHHCCCCHHHH | 41.33 | 21890473 | |
| 155 (in isoform 1) | Ubiquitination | - | 41.33 | 21890473 | |
| 168 | Ubiquitination | LQEQLWPHMEALRPR HHHHHHHHHHHHCCC | 18.35 | 21890473 | |
| 177 (in isoform 2) | Ubiquitination | - | 28.91 | 21890473 | |
| 182 (in isoform 2) | Ubiquitination | - | 39.88 | 21890473 | |
| 184 (in isoform 2) | Ubiquitination | - | 3.18 | 21890473 | |
| 208 | Methylation | AQQLEQIRRDIRDFR HHHHHHHHHHHHHHH | 29.88 | 115480665 | |
| 222 | Ubiquitination | RSSAGLDKVIVLWTA HHHCCCCEEEEEEEC | 38.61 | 21890473 | |
| 222 (in isoform 1) | Ubiquitination | - | 38.61 | 21890473 | |
| 258 | Ubiquitination | TIELGLEVSPSTLFA HHHHCCCCCHHHHHH | 14.17 | 21890473 | |
| 265 (in isoform 2) | Ubiquitination | - | 10.08 | 21890473 | |
| 305 | Ubiquitination | FVGGDDFKSGQTKVK EECCCCCCCCCHHHH | 61.75 | 21906983 | |
| 305 (in isoform 1) | Ubiquitination | - | 61.75 | 21890473 | |
| 310 | Ubiquitination | DFKSGQTKVKSVLVD CCCCCCHHHHHHHHH | 39.51 | 21906983 | |
| 310 (in isoform 1) | Ubiquitination | - | 39.51 | 21890473 | |
| 312 | Ubiquitination | KSGQTKVKSVLVDFL CCCCHHHHHHHHHHH | 36.08 | 21890473 | |
| 312 (in isoform 1) | Ubiquitination | - | 36.08 | 21890473 | |
| 351 | Phosphorylation | SAPLQFRSKEVSKSN CCCCEECCHHHCCCC | 34.16 | 25693802 | |
| 355 | Phosphorylation | QFRSKEVSKSNVVDD EECCHHHCCCCCCCH | 31.30 | 25693802 | |
| 356 | Ubiquitination | FRSKEVSKSNVVDDM ECCHHHCCCCCCCHH | 51.75 | - | |
| 357 | Phosphorylation | RSKEVSKSNVVDDMV CCHHHCCCCCCCHHH | 27.61 | 25693802 | |
| 385 | Phosphorylation | DHCVVIKYVPYVGDS CCEEEEEECCCCCCH | 8.78 | 21406692 | |
| 388 | Phosphorylation | VVIKYVPYVGDSKRA EEEEECCCCCCHHHH | 13.66 | 21406692 | |
| 392 | Phosphorylation | YVPYVGDSKRALDEY ECCCCCCHHHHHHHH | 20.36 | 21406692 | |
| 393 (in isoform 1) | Ubiquitination | - | 46.56 | 21890473 | |
| 393 | Ubiquitination | VPYVGDSKRALDEYT CCCCCCHHHHHHHHC | 46.56 | 21906983 | |
| 402 (in isoform 2) | Ubiquitination | - | 30.33 | 21890473 | |
| 473 | Phosphorylation | APLVPPGSPVVNALF CCCCCCCCHHHHHHH | 21.94 | 27050516 | |
| 476 | Ubiquitination | VPPGSPVVNALFRQR CCCCCHHHHHHHHCH | 3.83 | 21890473 | |
| 484 | Phosphorylation | NALFRQRSCIENILR HHHHHCHHHHHHHHH | 15.88 | 23911959 | |
| 514 | Phosphorylation | KMERPGPSLKRVGPV HCCCCCCCCCCCCCC | 53.06 | 26434776 | |
| 516 | Methylation | ERPGPSLKRVGPVAA CCCCCCCCCCCCCCC | 49.75 | 73915073 | |
| 516 | Ubiquitination | ERPGPSLKRVGPVAA CCCCCCCCCCCCCCC | 49.75 | - | |
| 524 | Phosphorylation | RVGPVAATYPMLNKK CCCCCCCCCCCCCCC | 20.58 | 21945579 | |
| 525 | Phosphorylation | VGPVAATYPMLNKKG CCCCCCCCCCCCCCC | 5.06 | 21945579 | |
| 530 | Ubiquitination | ATYPMLNKKGPVPAA CCCCCCCCCCCCCCC | 55.96 | 21890473 | |
| 530 (in isoform 1) | Ubiquitination | - | 55.96 | 21890473 | |
| 538 | Phosphorylation | KGPVPAATNGCTGDA CCCCCCCCCCCCCCC | 33.96 | - | |
| 557 | Phosphorylation | QEEPPMPTT------ CCCCCCCCC------ | 38.60 | - | |
| 558 | Phosphorylation | EEPPMPTT------- CCCCCCCC------- | 30.64 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of INO1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of INO1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of INO1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PP2AA_HUMAN | PPP2CA | physical | 16169070 | |
| THIM_HUMAN | ACAA2 | physical | 26344197 | |
| ALDOA_HUMAN | ALDOA | physical | 26344197 | |
| GDIR1_HUMAN | ARHGDIA | physical | 26344197 | |
| ECHM_HUMAN | ECHS1 | physical | 26344197 | |
| ERN2_HUMAN | ERN2 | physical | 26344197 | |
| HNRH2_HUMAN | HNRNPH2 | physical | 26344197 | |
| NACA2_HUMAN | NACA2 | physical | 26344197 | |
| 6PGD_HUMAN | PGD | physical | 26344197 | |
| PLSI_HUMAN | PLS1 | physical | 26344197 | |
| PPIB_HUMAN | PPIB | physical | 26344197 | |
| PPCE_HUMAN | PREP | physical | 26344197 | |
| PSMD9_HUMAN | PSMD9 | physical | 26344197 | |
| UCHL3_HUMAN | UCHL3 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...